Aims Methadone is widely used in maintenance programs for opioid-dependent subjects. The aims of the study were to quantify the distribution and excretion of methadone in human milk during the early postnatal period and to investigate exposure of breast fed infants to the drug. Methods Blood and milk samples were obtained from 12 breast feeding women who were taking methadone in daily doses ranging from 20-80 mg (0.3-1.14 mg kg −1 ). Blood was also obtained from eight of their infants. Methadone concentration in these samples was quantified by h.p.l.c. The infants were observed for withdrawal symptoms.
Introduction 1.9 [6-9]. Current recommendations on breast-feeding during methadone therapy are based on four studies (n= The number of persons attending methadone maintenance clinics in Australia has increased from approximately 2000 14), which were published 11-23 years ago [6] [7] [8] [9] . Although reviewers [10] [11] [12] generally have considered that breast in 1985 to more than 16 000 in 1995 [1] . A significant number of these are women of child bearing age who may feeding is safe during low dose methadone therapy (20 mg or less day −1 ), there is one case report where methadone wish to breast feed their infants. A recent retrospective study in New Zealand found that some 60% of mothers taking may have contributed to the death of an infant [13] . In addition, it has been suggested that the methadone dose methadone were breast-feeding when discharged from hospital [2] . requirement may need to be increased during pregnancy [6] , and in recent years there has been a general move to Methadone is a synthetic opioid drug used in maintenance programs worldwide for the treatment of opioid dependence. the use of higher daily doses in methadone programs [14] . There is also acknowledgment that a Neonatal Abstinence It is usually administered in a single oral dose each day. The drug has a half-life of around 27 h in tolerant individuals Syndrome (NAS), which is known to occur in 60-90% of infants born to mothers taking methadone [7, [15] [16] [17] [18] , is not [3] , and is metabolized in the liver by N-demethylation, ring cyclisation and conjugation [4] . The metabolites are ameliorated by breast-feeding [2] . This suggests that the amount of methadone in milk is insufficient to maintain the excreted in the bile and urine [4] . Methadone is highly lipid soluble and 89% protein bound. It is a weak base with a methadone concentrations to which the foetus has been exposed in utero. In the present study we report new data pKa of 8.25, an octanol5water ( pH 7.2) partition coefficient of 120 [5] , and a molecular weight of 309.4. Predicted characterizing the distribution/excretion of methadone in human milk in 12 women taking daily doses of methadone milk5plasma (M/P) ratios of around 0.65 [5] signs of NAS during this time.
over the range 0.005-0.8 mg l −1 with a correlation Methods coefficient of 0.999. The within-run coefficients of variation (CV) for the assay were 7.3% and 3.2% at 0.05 Materials and 0.8 mg l −1 respectively (n=8). The inter-day CV was 5.5% at 0.4 mg l −1 (n=8). The limit of detection ( peak Desipramine hydrochloride and methadone hydrochloride reference standards were obtained from Ciba-Geigy Australia height 3×baseline noise) was 0.005 mg l −1 but was higher for some infant plasma samples where limited sample Limited and Wellcome Australia Limited respectively. volumes were available. Aliquots of milk were analysed by the method of addition so as to avoid differential variation Patients in recovery of methadone and desipramine which occurs when milk samples, having different lipid contents, are Twelve breast-feeding women who were participants in a methadone maintenance program were enrolled in the extracted. Internal standard (0.01 ml of a 16 mg l −1 solution of desipramine in methanol) was added to 1 ml aliquots of study. Their mean age was 31 years (range 20-38 years) and their mean body weight was 63.1 kg (range 53-78 kg ). milk in 10 ml disposable polypropylene tubes. Each sample was assayed in triplicate with the addition of 50, 100, and They were maintained on a mean single daily oral dose of methadone hydrochloride (Methadone SyrupA; 5 mg ml −1 , 200 ng of methadone respectively. NaOH (0.2 ml, 1 m) was added to each tube and the samples were extracted as Wellcome Australia Ltd) of 43.3 mg (range 20-80 mg ). Their infants, who had a mean gestational age of 38.9 weeks described for plasma above. For each individual sample a standard curve relating added methadone concentration and (range 36-41 weeks) and a mean weight of 3.1 kg (range 2.37-3.78 kg ) were a mean of 6.7 days (range 3-26 days) peak height ratio (methadone5desipramine) was constructed and the concentration of methadone in the sample was post partum at the time of the study. During the week following their birth, the infants were monitored every 4 h obtained from the x-axis intercept. The within-run CVs for the milk assay were 6.6 and 8.1% at 40 and 400 mg l
and assessed for withdrawal symptoms using a Neonatal Abstinence Syndrome (NAS) scoring system adapted from respectively (n=5). H.p.l.c. analyses were carried out on a system comprising Finnegan et al. [19] , and treated with phenobarbitone according to hospital guidelines when appropriate.
a GBC Model LC 1610 Autosampler, Waters 6000A Solvent Delivery System, Waters 486 Tunable u.v. absorbance detector and a Goerz Model SE120 BBC chart recorder.
Study protocol
Analytes were separated on a Merck LiChrospherA 60, RP-Select B (5 mm×250 mm) column using a mobile The study design was approved by the Research and Ethics Committees of the King Edward Memorial Hospital, Centre phase of 42% v/v acetonitrile in 0.01% w/v NaCl and 0.01% w/v H 3 PO 4 , pumped at a flow rate of 1 ml min −1 . for Women's Health. Written informed consent was obtained from all participants. Two milk samples (10-20 ml) were collected using a manual breast pump, one immediately Calculation of infant dose before and one after the infant was breast fed, and a mean methadone milk concentration obtained from these. A
The absolute infant methadone dose was calculated from the average of the pre-and post-feed milk concentrations heparinized venous blood sample (6 ml) was obtained from the mother usually immediately following the post-feed assuming an infant milk consumption of 0.15 l kg −1 day −1 [20] , and a bioavailability of 100%. The relative dose of milk sample. In eight cases, immediately following the final milk sample collection, a heparinized venous blood sample methadone, expressed as percentage of maternal dose received by a nursing infant, was calculated from the (0.5-1 ml) also was taken from the nursing infant. Breast milk sampling times were calculated from the time of absolute dose×100, divided by the maternal dose where both doses are expressed in mg kg −1 day −1 . last dose to the mid-point of the feed.
Statistical evaluation of data H.p.l.c. analysis of methadone in plasma and milk
Aliquots of plasma (1 ml) were mixed with desipramine Data have been summarized as mean (95% CI) or mean (range) as appropriate. Methadone concentration in pre-and (internal standard; 0.01 ml of a 16 mg l −1 solution in methanol) in 10 ml screw-capped disposable polypropylene post-feed milk samples were compared using a paired Student's t-test. Relationships between maternal plasma tubes. NaOH (0.2 ml, 1 m) was added to the plasma and the samples were extracted with 9 ml of 1% v/v isoamyl methadone concentration and the time after birth at which the NAS score was ≥8 on two subsequent 4 hourly alcohol in hexane by shaking vigorously for 5 min. After centrifugation (5 min at 1500 g), 8.5 ml of the organic phase observations, or when phenobarbitone treatment was started (shorter time interval used) were investigated by linear was aspirated to a clean tube and back-extracted into 0.2 ml of 0.05 m HCl by shaking vigorously for 1 min. After regression and correlation analyses. further centrifugation, the organic phase was aspirated and discarded and 0.04 ml aliquots of the acid phase were Results injected directly onto the h.p.l.c. Unknown samples were interpolated from a linear plot of the peak height ratio for
The daily maternal methadone dose ingested, methadone concentrations in maternal plasma and milk, and milk/ methadone5desipramine versus known concentrations of methadone in plasma. The plasma standard curve was linear plasma (M/P) ratios are shown in Table 1 . Maternal daily were collected from eight infants and plasma methadone concentration was below the assay limit in seven infants and (Figure 1) . The mean time between the two samples in these patients was 1.15 h (0.67-1.63). Overall, the post-feed measurable at 6.5 mg l −1 in the remaining infant. Of the twelve infants in the study, eight required observation in milk methadone concentration was significantly ( P=0.01) higher, by a mean of 26 (7-43) mg l −1 or 33% (10-56%), the Special Care Nursery. Seven (64%) were assessed as having NAS, and six of these required treatment ( phenobarthan that in the pre-feed milk. Patient DM was excluded from the latter sub-analysis because her pre-and post-feed bitone) for their symptoms. There was no significant correlation or regression between time to NAS/phenobarbimilk samples were obtained from two successive feeds that were 6 h apart. tone treatment and either maternal plasma methadone concentration, or estimated infant methadone dose in milk. Table 2 summarizes the demographic characteristics of the recommend that women on a methadone maintenance Discussion program should not be discouraged from breast feeding. However further studies are required in women who are In this particular group of women, who were inpatients and in the early post partum period (with the exception of TI), breast feeding older infants and those who are maintained on larger daily methadone doses. there were logistic difficulties in obtaining multiple paired plasma and milk samples. Thus we were only able to make This study was supported by a research grant from the Women and Infants Research Foundation, Western single point observations of M/P distribution for each of the 12 patients. While multiple sampling within a dose Australia. interval and the use of area under the curve measurements in plasma and milk is generally recommended [21] , it is References critical only for drugs with a short t 1/2 . Since methadone has a long t 1/2 of around 27 h [3], single point sampling is fat of colostrum to that of mature milk in 2-3 weeks [22] . exposure is less than half the average daily infant exposure and was insufficient to prevent NAS in 64% of infants. We
